. Design and characterization of a multifunctional pH-triggered peptide C8 for selective anticancer activity. Advanced Healthcare Materials, 4(17), 2709-2718. DOI: 10.1002/adhm.201500636
Abstract:
Most drug delivery systems have been developed for efficient delivery to tumor sites via targeting and on-demand strategies, but the carriers rarely execute synergistic therapeutic actions. In this work, C8, a cationic, pH-triggered anticancer peptide, was developed by incorporating histidine-mediated pH-sensitivity, amphipathic helix and amino acid pairing self-assembly design. The design strategy renders C8 as pH-responsive nanostructure that is switched on and off by cytotoxicity: Non-cytotoxic β-sheet fibers at high pH with neutral histidines, and positively charged monomers with membrane lytic activity at low pH. The selective activity of C8, tested for three different cancer cell lines and two noncancerous cell lines, is shown. Based on liposome leakage assays and multiscale computer simulations, we propose its physical mechanisms of pore-forming action and selectivity, which originate from differences in the lipid composition of the cellular membrane and changes in hydrogen bonding. C8 is then investigated for its potential as a drug carrier. C8 forms a nanocomplex with ellipticine, a non-selective model anticancer drug. It selectively targets cancer cells in a pH-responsive manner, demonstrating enhanced efficacy and selectivity. This study provides a novel powerful strategy for the design and development of multi-functional self-assembling peptides for therapeutic and drug delivery applications.
Introduction
Nanotechnology offers tremendous possibilities for drug delivery systems to overcome the adverse effects of conventional chemotherapeutics and improve their anticancer bioactivity via passive or active targeting of the tumor. [1] In particular, stimuli-responsive systems provide an attractive alternative for on-demand delivery. [2] Unlike ligands that target the surface of cancer cells, stimuli-responsive delivery systems react to external stimuli, such as temperature, [3] pH, [4] light, [5] or extracellular up-regulated enzymes, [6] resulting in the release of the drug at the tumor site. To suppress toxic side effects and enhance therapeutic efficacy, combinations of multiple functionalities, involving longevity, targetability, stimuli-responsiveness and cell penetration, are under development. [2] Peptides are a promising class of molecules for bio-application owing to their design flexibility, biocompatibility, and bio-functionalities.
[7] Self-assembling peptide systems with controlled nanostructures and responsiveness to stimuli have been developed to optimize pharmacological properties for drug delivery. [8] Multifunctional self-assembling peptide-based nanocarriers that release loaded drug in a pH-dependent manner have been reported to be effective in inhibiting tumor growth. [9] In addition, many cationic peptides can also provide functions including cell penetration [10] and nuclear-targeting.
[11] Some of them show anti-cancer activity by inducing membrane disorder and permeabilization via several mechanisms [12] and they exhibit selectivity towards cancerous cells, making them advantageous over conventional chemotherapeutics. [12a] This selectivity is often attributed to electrostatic interactions between the positively charged peptides and negatively charged cancer cell surfaces. [12a, 13] However, the detailed mechanisms of controlling selectivity remain unknown.
Recently, Christina et al. reported that intermolecular interactions within the nanostructure (termed as "intermolecular cohesion") of membrane active molecules affected their association with cell membrane. [14] This inspired us to design an anticancer peptide-based system with controllable lytic activity. Here, we report the design and characterization of C8, a pH-triggered self-assembling anticancer peptide. C8 self-assembles into non-lytic nanofibers and disassemble into lytic monomers or oligomers in response to changes in pH. We hypothesize that the formation of stable nanofibers limits the association between C8 and the membrane, resulting in inactivated lytic function, while disassembled C8 monomers can insert into the membrane and adopt bioactive conformations leading to lytic activity ( Figure 1C ). Furthermore, C8 shows selective cytotoxicity towards cancerous cells. Multiscale molecular dynamics (MD) simulations, and a variety of characterization methods and liposome leakage studies were used to investigate the mechanisms of selectivity. Such an interdisciplinary approach has proven very fruitful in related systems. [5, 15] C8 was tested as a carrier for a model anticancer drug, ellipticine (EPT). This system shows pH-triggered cytotoxicity with enhanced therapeutic efficacy, and moreover exhibits selective cytotoxicity towards cancerous cells (EPT is not selective itself).
Results

Rational Design and Characterization of C8
The anticancer peptide C8 was designed to provide lytic activity and stimuli-responsive selfassembling nanostructures. First, to be able to induce membrane lysis, [16] the peptide should possess separated hydrophobic and hydrophilic faces when adopting an α-helical conformation on phospholipid membranes ( Figure 1A) . Second, according to the amino acid pairing principle,
[7c] the amino acids that provide different types of side chain interactions are alternatively arranged in the sequence, leading to paired side chain interactions. This usually allows the peptide to form β-sheets in aqueous solutions and facilitate the stacking of the β-sheets [7c] ( Figure 1B ). Histidine residues (pKa~6) are used to induce electrostatic repulsion at acidic pH, providing a mechanism to control assembly and disassembly of nanostructures ( Figure  1B ). Asparagine residues are used to provide side chain hydrogen bonding and further strengthening intermolecular cohesion.
C8 was first characterized using circular dichroism (CD) spectroscopy and atomic force microscopy (AFM) at pH 8.0 and 4.0, where most of the histidine residues are neutral and protonated, respectively. The spectrum of C8 at pH 8.0 had a positive band at 195 nm and a negative one at 216 nm, indicating β-conformation. [17] The negative band is broad, however, suggesting simultaneous existence of helical conformations. This might be promoted by intramolecular hydrogen bonding as neutral histidine residues act as both hydrogen bond acceptors and donors ( Figure 1D ). The AFM image ( Figure 1G ) confirmed the formation of nanofiber networks. When pH was decreased to 4.0, C8 became largely unstructured with a negative peak centered at ~200 nm ( Figure 1D ). The AFM image showed "melted", disassembled nanofiber networks ( Figure 1H ). The critical assembly concentration (CAC) of C8 was determined using the 1-anilino-8-naphthalene sulfonate (ANS) fluorescence assay. In a hydrophobic environment, the wavelength of maximum emission (λmax) of the ANS dye undergoes a blue shift. Figure 1E shows that shifts in λmax are significant at concentrations above 5 mM at pH 8.0, corresponding to nanofiber formation and suggesting CAC of ~5 mM. In contrast, the disassembled C8 showed lower propensity for hydrophobic encapsulation of ANS as shifts in λmax were not significant at pH 4.0. However, when C8 concentration was increased above 40 mM, the λmax shifted to a lower wavelength dramatically, which may result from the presence of fibrils or small aggregates. The hydrophobic nature of ANS could also induce the formation of nanostructures at high C8 concentrations, which would be an alternative explanation. The intrinsic fluorescence emission of tryptophan was monitored at both pH 4.0 and 8.0. The λmax of tryptophan was found to be 355 nm at pH 4.0, and blue shifted to 344 nm at pH 8.0 ( Figure  S1 ), indicating that tryptophan located at the hydrophobic core of C8 nanofiber. This is in line with our proposed mechanism of self-assembly ( Figure 1B ): when forming a nanofiber, it is likely that the hydrophilic arginine residues are exposed to water, with the other residues forming the hydrophobic core of the nanofibers. We also found that increasing temperature facilitates the self-assembly process ( Figure S2 -5) and even altered the nanostructure morphology ( Figure S3 and S4). This is in accord with Banwell et al. [18] who found that in contrast to hydrogen bonded peptide fibril networks, peptide networks controlled by hydrophobic interactions become stronger upon heating. Above we hypothesized that nanostructure formation would prevent the α-helical folding of C8 at the phospholipid membrane surface ( Figure 1C ). This was investigated by monitoring the secondary structure of C8 in the presence of model lipid membranes, before and after nanostructure formation. As shown in Figure 1F , the CD spectrum of freshly dissolved C8 had two minima at 209 nm and 225 nm, respectively, which suggest mixed conformations of helices and β-turns; [17] this may result from the presence of NaCl which further screened the positive charges. When POPC liposomes were added into the C8 solution, the CD spectrum of C8 was indicative of α-helical conformations. After 1 day incubation, the spectrum showed a broad negative band at ~216 nm, suggesting mixed conformation of helices and β-sheets. After 1 day with POPC liposomes, C8 remained as a mixture of helices and β-sheets, indicating hindered insertion of C8 into model membranes ( Figure 1F ).
Nanostructure-dependent Lytic Action of C8
Cytotoxicity of nanostructured and unstructured C8 was evaluated on three cancer cell lines: A549 (non-small cell lung carcinoma), U87MG (glioblastoma) and MCF7 (breast carcinoma). Nanostructured C8 did not inhibit, and even slightly enhanced, the growth of the cells (Figure  2A) . In contrast, unstructured C8 was active in killing the cells mainly via causing acute damage (Figure 2A and S6) and it was effective in inhibiting growth of an A549 tumor on nude mice via intratumoral injection ( Figure S7 ). The nanostructure formation is associated with the deprotonation of histidine, which could be one reason for the "off-switch" for lytic action. To investigate the roles of histidine protonation and nanostructure on the lytic activity of C8, we prepared two C8 samples at pH 5.4 but incubated them at 0 °C or 37 °C to obtain unstructured or nanostructured C8 ( Figure S2 and S3). The cytotoxicity results show that nanostructured C8 does not kill cells while the unstructured C8 is still lytic but less active than C8 prepared at pH 4.0 ( Figure S8 ). This observation suggests that the nanostructure formation, as we hypothesized, is the major factor that inactivated the lytic function, although the protonation state of histidine also affects lytic activity. We also observed that the samples prepared at pH 7.4 were still effective against the cancer cells before the condensed fiber networks formed, further confirming the nanostructure-dependent lytic activity. Hemolytic effect of C8 was evaluated, showing that nanostructure formation may limit its hemolytic activity ( Figure S9 ), one of the major side effects of many cationic lytic peptides.
Membrane disruption induced by C8 was visualized using SEM (scanning electron microscopy) and AFM. Representative SEM images of untreated A549, and A549 cells treated with nanostructured or unstructured C8 samples are shown in Figure 2C . The untreated and the nanostructured C8 treated cells have intact membranes with smooth surfaces. The cells treated with the unstructured C8 sample have rough and porous membrane surfaces, indicating membrane disruption. The AFM images showed the same observations ( Figure 2D ).
Membrane Selectivity and Lysis
The selectivity of C8's lytic activity was investigated using two non-cancerous cell lines, NIH-3T3 (fibroblast) and HUVEC (Human Umbilical Vein Endothelial Cells). Nanostructured C8 was non-toxic towards non-cancerous cells. Unstructured C8 exhibited cytotoxicity, but it was significantly lower than against cancerous cells at low peptide concentrations ( Figure 2B ).
To address the mechanisms controlling C8 selectivity and cell lysis, leakage of calcein from large unilamellar vesicles was measured in aqueous buffer solution (10 mM Tris, 110 mM NaCl, pH 7.4). At low concentrations (sub micromolar), C8 induced leakage from both pure POPC liposomes and POPC bilayers with 20 mol% cholesterol ( Figure 3A) . A model bacterial membrane with polar lipid extracts of E.coli (predominantly POPE/POPG mixture) required roughly 10 times higher concentration of C8 to induce leakage. A ring test also showed that C8 does not have antimicrobial activity ( Figure S10 ). This supports C8's unusual membrane selectivity.
Multiscale simulations [19] combining atomistic and coarse-grained MARTINI [20] MD were used to characterize C8 aggregation and pore formation in different model membranes. Similar multiscale approaches and protocols have been successfully used in studies of amyloid peptides. [21] First, coarse-grained simulations (1 μs) were used to study C8 aggregation within the membrane core. These structures were then converted [22] to an atomistic model (GROMOS54A7 force field, [23] simulation protocols following Refs. [20] [21] ), and the simulation was continued for 100 ns. Figure 3C shows atomistic stimulations for C8 aggregates in 3 model membranes: pure POPC, 20 mol% cholesterol/POPC, and 1:3 POPG:POPE mixtures (modeling E. coli membrane). When all three histidines are neutral (corresponding to pH 8), the peptide aggregated and no large pores were observed in any of the systems. Next, to simulate the pH 4 conditions, positive charges were assigned to histidines. This caused relatively large, dynamic, disordered toroidal pores to appear in the POPC and the 20 mol% cholesterol membrane. This is consistent with the observation that less charged histidine caused less lytic activity ( Figure S8 ). No such pores formed with the POPE/POPG mixture. The qualitative features of the disordered toroidal pores, with water and lipid head groups pulled inside the hydrophobic core, match previous MD simulations. [24] The hydrophilic pores enable the polar calcein molecules to easily cross the POPC and 20 mol% cholesterol bilayers ( Figure 3C ) as observed in experiments ( Figure 3A ). There are ~30 % more hydrogen bonds formed between charged C8 and POPG and POPE lipids, compared to C8 with the pure POPC lipids ( Figure S11 ). Despite the 3:1 POPE:POPG mixture there are ~97% more hydrogen bonds between C8 and POPG compared to POPE. The strong interactions between C8 and PG lipids could stabilize the interfacial conformation over the transmembrane-pore forming conformation.
We calculated free energy profiles for single C8 molecules to move from water to the center of the three model membranes ( Figure 3B ) using the MARTINI model. For the POPE/POPG mixture, C8 prefers to interact with the water-lipid interface, due to the strong electrostatic interactions between the peptide and the PG head group ( Figure S12 ). The deep free energy minima at the interface of the PE/PG mixture confirms our hypothesis that the negatively charged PG attracts C8 to the interface and reduces pore formation. The high free energy cost for a single C8 to be at the center of the POPC and 20 mol% cholesterol system explains the rapid aggregation of peptide into amphipathic helices. The increased hydrophobicity of aggregated peptides could be a possible driving force that overcomes the ordering effect of cholesterol.
[25]
Peptide-drug Nanocomplex and Characterization
To test the potential of C8 to act as a hydrophobic anticancer drug carrier, ellipiticine (EPT) was complexed with C8 at pH 8.0. Like pure C8, C8-EPT assembled to form nanofibers ( Figure 4A ). Compared to pure C8 nano fibers, C8-EPT nanocomplexes were thicker (average width ~21±3 nm vs. ~38±8 nm). The secondary structure of C8 (using CD) in the nanocomplex indicates a major β-sheet population mixed with α-helices ( Figure 4C ), similar to pure C8. The fluorescence spectrum of EPT indicated that it remained mostly deprotonated and neutral, based on the emission peak centered at ~430 nm ( Figure 4B) . [26] Hydrophobic EPT molecules were likely reside between peptide sheets, interacting with hydrophobic side chains of isoleucine and tryptophan. The C8-EPT nanocomplex "melted" to short fragments at pH 4.0 ( Figure 4A ) with a significant reduction in β-sheet content ( Figure 4C ), indicating the disassembly of nanofibers. Protonated EPT (fluorescence emission peak centered at 530 nm) became dominant at low pH [27] ( Figure 4B ) destabilizing the nanocomplex and facilitating the release of EPT. The assembly of C8-EPT nanofibers at pH 8.0 and their disassembly at pH 4.0 were confirmed by TEM ( Figure  S13 ).
pH-triggered Selective Drug Delivery
Peptides are widely used to functionalize drug carriers for enhanced intracellular and intranuclear delivery. [10a, 11] C8, the functional peptide here, also works as a delivery vehicle. To demonstrate this multi-functionality, the in vitro cytotoxicity of C8-EPT nanocomplex (referred as C8-EPTpH8) and disassembled C8-EPT (referred as C8-EPT-pH4) was evaluated on A549 cells. The C8-EPT-pH8 exhibited low toxicity, while neutral EPT showed strong cytotoxicity ( Figure S14 ). C8-EPT-pH4 was active in inhibiting cell growth (Figure 5B) , demonstrating a pH-triggered mechanism. Furthermore, C8-EPT-pH4 presented significantly enhanced cytotoxicity when compared to unstructured C8 control ( Figure 5B ) and protonated EPT control ( Figure 5A and S15). We also performed one-hour treatments with C8-EPT-pH4 and EAK16-II-EPT [27] drug delivery systems. In the latter, the self-assembling peptide EAK does not possess membrane activity. The C8-EPT-pH4 showed strong cytotoxicity and the morphologies of the treated cells changed within 2 min, while one hour was too short for EPT to induce apoptotic cell death ( Figure S16 ). These results strongly suggest that C8 retains its lytic action in the C8-EPT-pH4 system. These results demonstrate that EPT and C8 worked simultaneously and synergistically.
The reason for the enhanced cytotoxicity of C8-EPT-pH4 and the low cytotoxicity of C8-EPTpH8 against A549 cells was further explored using confocal laser scanning microscopy (CLSM) and fluorescence-activated cell sorting (FACS) technique. As shown in Figure 5D , EPT is present in cells as neutral and protonated. The presence of neutral EPT in the cytoplasm may due to cellular uptake of EPT via passive diffusion or deprotonation of EPT in relative neutral environment of cytoplasm. [28] Because the binding of protonated EPT molecules to negatively charged DNA is the primary mechanism for EPT, [28] the intracellular distribution of protonated EPT was investigated. After 4 h of incubation, protonated EPT was distributed in the cytoplasm with a small part entrapped in the endolysosomes (judged by the yellow fluorescence) in EPT treated cells. The C8-EPT-pH8 treated cells showed that protonated EPT mostly localized in endolysosomes. The EPT molecules were still mainly distributed in cytoplasm of the cells treated with EPT or C8-EPT-pH8 for 18 h ( Figure S17 ). In contrast, protonated EPT accumulated in the nuclei of the cells treated with C8-EPT-pH4 for 4 h ( Figure 5D ). Increased blue fluorescence and the MD simulations suggest increased permeability of cytoplasmic membranes of cells treated with C8-EPT-pH4, which facilitated the entry of neutral EPT molecules. Furthermore, the MD simulations suggest that EPT may diffuse through the hydrophilic pores formed by C8 (Figure 3) at pH 4. The cellular uptake of EPT was studied using FACS. As shown in Figure 5G , A549 cells treated with C8-EPT-pH4 showed enhanced cellular uptake when compared to EPT treated cells. Cellular uptake of C8-EPT-pH8 was low, while most of the internalized nanocomplexes were entrapped in endolysosomes, resulting in low cytotoxicity. When disassembled, the free C8 peptides permeabilized the cytoplasm membranes, facilitating uptake of EPT and its accumulation into nuclei. As nuclear targeting peptides are mostly cationic, [11] it is reasonable to suggest that C8 also has the ability to target nuclei. MD simulations and liposome leakage data showed that lipid composition affects the ability of C8 to form pores (Figure 3 ), which may be utilized to achieve selective delivery of EPT. This was investigated using A549 and NIH-3T3 cells. IC50 value of unstructured C8 was ~20.9 μg ml -1 (9.0 μM) on A549 cells and ~40.5 μg ml -1 (17.5 μM) on NIH-3T3 cells ( Figure 5B ,C). Why C8 is more cytotoxic on A549 cells may be explained by the MD simulations that show the free energy cost and the inability of C8 to form pores in POPG-containing membranes ( Figure 3B,C) . Because C8 is less active against NIH-3T3 cell lines than A549, when treating both cell lines with the same concentrations of C8-EPT-pH4, the unstructured C8 causes less damage to the NIH-3T3 cell membranes, leading to less efficient cellular uptake. Cytotoxicity of protonated EPT control against A549 and NIH-3T3 cell lines was found to be not particularly selective, with IC50 of 2.5 μg ml -1 (10.2 μM) on A549 cells and 2.4 μg ml -1 (9.8 μM) on NIH-3T3 cells ( Figure  5A ). As shown above, the delivery depended on the membrane activity of C8. Comparing the cytotoxicity of C8-EPT-pH4 against A549 (IC50 of 12.1 μg ml -1 C8 and 1.2 μg ml -1 EPT) and NIH-3T3 (IC50 of 21.1 μg ml -1 C8 and 2.1 μg ml -1 EPT) cell lines ( Figure 5B ,C and S14), we found that C8-EPT-pH4 was indeed more active against A549 cells. Although C8-EPT-pH4 exhibited higher cytotoxicity against NIH-3T3 cells when compared to the C8 control ( Figure  5C ), the cytotoxicity of C8-EPT-pH4 was mostly contributed by EPT ( Figure S15 ), implying that the synergism between C8 and EPT was weakened due to less activity of C8 against NIH-3T3 cells. This is further evidenced by FACS data: C8-EPT-pH4 treated cells showed comparable EPT uptake to EPT treated cells, while C8-EPT-pH8 treated cells had the lowest EPT uptake ( Figure 6H ). With further dilution, C8 was incapable of disrupting the cell membranes of both cell lines and C8-EPT-pH4 became less active against both cell lines.
To further explore the potential of the enhanced and selective delivery, instead of water, we used C8 aqueous solution at pH 4 at a concentration of 15 μg ml -1 (6.4 μM) to dilute C8-EPTpH4 (referred to as C8-EPT-pH4+). The idea is to maintain the concentration of C8 at a level at which C8 is capable of disrupting the A549 membrane but not the NIH-3T3 membrane after series of dilutions. C8 samples at corresponding concentrations were used as controls to show the contribution of C8 to the cytotoxicity of C8-EPT-pH4+. As shown in Figure 5E , the C8-EPTpH4+ had a significant enhancement in its cytotoxicity against A549 cells. Even diluted 32-fold, C8-EPT-pH4+ still showed an enhancement in cytotoxicity when compared to C8, inhibiting ~25% more cell growth ( Figure 5E ). In contrast, no significant enhancement was observed on the cytotoxicity of C8-EPT-pH 4+ against NIH-3T3 cells when compared to C8-EPT-pH4 ( Figure 5F and S15). In summary: C8-EPT-pH4+ showed an enhanced selectivity towards A549 cells ( Figure S18 ).
Discussion
We have designed and characterized C8, a novel anticancer peptide that also functions as a delivery vehicle for other anticancer drugs. This multi-functionality has the benefit that both the delivered drug and delivery vector can execute separate therapeutic functions. We used an innovative strategy for the design of C8. The difficulty in the design is how to integrate stimuliresponsive nanostructures and lytic activity into one peptide sequence. The anticancer peptide amphiphiles developed by Samuel et al. also form β-sheet rich nanofibers that possess lytic activity.
[29] In their case, the membrane-active portion does not participate in the β-sheet formation, being free end to insert into membranes. In contrast, in our design the entire peptide participates in constructing the self-assembled nanostructures ( Figure 1B) ; when histidine is deprotonated, the alternating hydrophobic and hydrogen bonding side chains stabilize the nanostructures, hindering the membrane insertion of C8 ( Figure 1C ). This is consistent with computer simulation results, which revealed that hydrogen bonding and hydrophobic side chains provide strong intermolecular cohesion, [14] preventing release of peptides from the nanostructures. This work provides novel insight into C8's selectivity and membrane activity that will facilitate the design of future anticancer peptides. C8 has unusual membrane selectivity compared to many traditional antibiotic and anticancer cationic lytic peptides. C8 does not have antimicrobial activity but does selectively kill cancer cells. We linked the cell selectivity of C8 with the content of PG and cholesterol, providing new insights to understand the mechanism of the selective activity of lytic peptides. Traditionally, cationic peptides' membrane selectivity has been attributed to the negatively charged surfaces of both cancerous and bacterial cell membranes and lower cholesterol content in bacterial membranes. [12a, 13] Our data suggest that this may be too simplistic possibly due to multiple histidine residues. Due to the complexity of cell membrane composition, the selectivity of cationic lytic peptides would result from combinational effects.
C8 was shown to be able to selectively deliver EPT to cancer cells and enhance its therapeutic efficacy. EPT is likely encapsulated in the non-toxic C8 nanofibers, at pH 8, which limits its toxicity. When the nanocomplex reaches the targeted environment (in our case low pH), the peptide nanofibers disassemble to release active monomers and the encapsulated EPT. The synergetic effect of cationic lytic peptides and chemotherapeutic drugs has been shown in previous works. [30] The selectivity of C8 and the synergistic effect with the EPT could reduce its toxic side effects. The continued in vivo application of therapeutic peptides could enhance the uptake of the drug, given the concentration dependent selectivity that we observed. The high cost of manufacturing peptides is an issue that hinders the application of peptide-based therapeutics. [12a, 31] With the help of the delivered drug we can achieve the same level of therapeutic efficacy with a lower concentration of peptide, but still maintain selectivity towards cancerous cells, resulting in reduced cost. Another advantage of anticancer peptides is their ability to combat drug-resistant species, which might be due to their fast mode of action. [32] We have found that C8 could facilitate the accumulation of EPT into nuclei within 15 min ( Figure  S17 ), which suggests anticancer peptides may make the delivered anticancer drug insusceptible to multidrug resistance generated by cancer cells.
C8 presents a leap towards rational peptide design, combining our amino acid pairing principle, knowledge of amphipathic helices, and pH sensitive histidine residues. Due to the chemical flexibility of peptides, slight changes to the sequence of C8 may improve its efficiency and selectivity. The shape and size of self-assembling peptide materials can be also tailed to improve their pharmacological properties in vivo, [8a] which could be investigated in future studies. The C8-EPT system represents a novel type of multifunctional drug delivery system and a starting point for design of future peptides.
Conclusions
We introduce the design of C8, an anticancer peptide with pH-triggered nanostructure and activity. Ionizable histidine residues were used to incorporate pH-sensitivity for reversible selfassembly. The amphipathic design enables pore formation by disassembled C8 while the design based on the amino acid pairing principle incorporating multiple asparagine residues contributes to strong intermolecular interactions, resulting in non-toxic assemblies. C8 showed selective cytotoxicity towards cancerous cells. We suggest the selectivity to originate from the differences in the lipid composition of cell membranes, resulting in changes in hydrogen bonding with C8. C8 was shown to be capable of forming a nanocomplex with anticancer drug ellipticine. This nanocomplex was tested on A549 lung carcinoma and NIH-3T3 fibroblast cells, showing pHtriggered delivery with enhanced anticancer activity and cancer cell selectivity. Our work demonstrates the feasibility of using molecular self-assembly to design multifunctional anticancer peptides for drug delivery.
Experimental Section
Sample Preparation: C8 peptide was purchased from Canpeptide Inc. (Montreal, Canada) with purity above 95%. The peptides were dissolved in Mili-Q water to give a 80 μM stock. In the hemolysis study, C8 aqueous solutions (430 μM) at pH 7.4 or pH 4.0 were prepared as stock solution 3 or 5 days before use. The pH of the peptide solution was adjusted using hydrogen chloride solution or sodium hydroxide solution. The C8-EPT nanocomplexes were prepared by adding EPT (ENZO life science, Canada) (0.05 mg ml -1 ) into C8 aqueous solution (0.5 mg ml -1 ) at pH 4.0. After EPT powder dissolved, the pH was adjusted to 8.0 by adding sodium hydroxide solution. The sample was stirred using a magnetic bar at 900 rpm overnight. The disassembled C8-EPT sample was prepared by adding hydrogen chloride solution into pH 8.0 samples and incubated for 2 days before usage. The pH value was measured using a microprobe pH meter (Accumet, Canada) and was in the range of ±0.2 of the targeted value. Fluorescence spectroscopy: The intrinsic tryptophan fluorescence of C8 peptides was monitored on a QM4-SE spectra fluoremeter (PTI, Canada). The emission spectra of C8 peptides (λex 280 nm) were collected from 310 nm to 400 nm. The slit widths of excitation and emission were set at 2 nm and 8 nm, respectively.
The ANS fluorescence assay was described previously.
[7c] The C8 solutions (pH 8.0, 1 d incubation) were mixed with the same volume of the ANS solution on a vortex mixer for 10 s. The mixtures were then excited at 360 nm on a QM4-SE spectra fluoremeter (PTI, Canada). The fluorescence emission was normalized with light scattering of air at 360 nm to correct the lamp fluctuations.
The molecular state of EPT was identified using fluorescence spectroscopy. The samples were transferred into a square quartz cell and excited at 295 nm. The emission scans were performed on a QM4-SE spectra fluoremeter (PTI, London, Canada). Detailed experimental settings have been described previously. [27] The fluorescence emission of C8 solution at corresponding pH was subtracted from the data as background. Circular Dichroism Spectroscopy: The secondary structure of C8 peptides in aqueous solution, in the presence of model lipid membranes or in C8-EPT nanocomplex was determined by circular dichroism on a J-715 circular dichroism spectrometer (Jasco Europe, Italy) using 1 mm quartz cells (Hellma, Canada). All the spectra were averaged from two replicates and solvent absorbance was subtracted from the data. The mean residue molar ellipticity of C8 peptide presented here was calculated following the formulas: Ellipticity (θ in deg cm 2 dmol −1 ) = (millidegrees mean residue weight)/(path length in millimetres concentration of C8 peptide in mg ml -1 ). [33] Microscopy: The morphologies of C8 peptides or C8-EPT nanocomplex were imaged on a Dimension Icon AFM (Bruker, USA). A 50 μl sample solution was mounted on a freshly cleaved mica surface (SPI, USA). Following 15 min incubation, the mica was washed with 80 μl Mili-Q water 5 times. After drying, AFM imaging was performed at room temperature using the peak force quantitative nanomechanical mapping (PF-QNM) mode. All images were acquired using a SCANASYST-AIR probe (Bruker, USA).
To obtain electron micrographs of C8 self-assembly and C8-EPT nanocomplex, 10 μL of sample solution of C8 peptide or C8-EPT complex was applied to a 400 mesh Formvar coated copper grid (Canemco-Marivac, Canton de Gore, Canada) for 3-5 min, followed by 5 successive wash and dried overnight. The sample was then stained with uranyl acetate and imaged using A Philips CM 10 transmission electron microscope (Amsterdam, Netherlands) at an accelerating voltage of 80 kV.
To prepare the cell samples for AFM or SEM, A549 cells were seeded on coverslips, which were placed into a 6-well plate containing 150,000 cells. The cells were incubated for 24 h at 37°C and 5% CO2. After removing the media, 1.5 ml of media and 500 μL of sample were added into each to make a final concentration of 5 μM for unstructured C8 sample and 20 μM for nanostructured C8 sample. Following 3 h incubation under the same conditions, peptide solutions were removed, and then cells were washed with 1 mL of PBS for fixation. The cell fixation protocol was described previously. [13] For AFM, the morphology of A549 cells was also imaged using the Dimension Icon AFM (Bruker, USA) at room temperature. The MLCT probes consisting of silicon nitride cantilevers (nominal spring constant of 0.01 N m -1 ) with silicon nitride tips (tip radius of around 20 nm) were used. Topography was imaged by contact mode with low deflection set point and the scan rate was 0.5 Hz to minimize the disturbance during the scan process. For SEM, the coverslips were mounted on metal stubs using double-sided sticky conductive tape. Then, the cells were sputter coated with 10 nm gold and imaged in a ULTRA plus SEM (Zeiss, Germany). MTS Assay: To determine the pH-trigged, selective cytotoxicity of C8, A549 or HUVEC cells were seeded in 96-well plates at a density of 5×10 3 cells per well, while MCF7, U87MG and NIH-3T3 cells were seeded at a density of 1×10 4 cells per well. A549, MCF7, U87MG and NIH-3T3 cells were incubated for 24 h before treatment, and HUVEC cells were incubated for 48 h before treatment. The cells were exposed to nanostructured C8 or unstructured C8 for 24 h. Mili-Q water at corresponding pH was added as 0 μM samples. In the C8-mediated drug delivery part, A549 (1×10 4 cells per well) or NIH-3T3 cells (2×10 4 cells per well) were seeded in 96-well plates. After incubation for 24 h, the cells were exposed to EPT control solutions or C8-EPT samples for another 24 h. Afterwards, MTS assays were performed using a CellTiter 96® AQueous Kit (Promega, USA) according to the manfacture's protocol. The absorbance was measured at 485 nm using a Fluostar plate reader (BMG, Germany). The untreated cells were used as a control of 100% viability. Intracellular Trafficking: A549 cells (8×10 4 cells per well) were seeded onto 4-well chambered coverglasses (Lab-Tek, USA) and cultured for 24 h, following by adding protonated EPT solution (6.3 μM), C8-EPT-pH8 or C8-EPT-pH4 (6.7 μM C8 and 6.3 μM EPT, which correspond to the concentration of 8X samples used in cytotoxicity study). After incubation for 15 min, 4 h or 18 h at 37 °C, the cells were washed by 4 °C PBS three times, and then stained by LysoTracker Deep Red (50 nM) (Life Technologies, Canada) at 37 °C for 15 min. Finally, the cells were washed by 4 °C PBS three times and observed using an Olympus Fluoview FV1000 confocal laser scanning microscope (Olympus, USA). EPT was excited with a 405 nm diode laser (15 mW). The emission setting was at 430-460 nm for neutral EPT and at 520-560 nm for protonated EPT. LysoTracker Deep Red was excited with a 635 nm laser (20 mW) with a emission setting at 650-750 nm. Cellular Uptake of EPT: A549 (8×10 4 cells per well) or NIH-3T3 (1.6×10 5 cells per well) cells were seeded in 24-well plates. After culture for 24 h, the cells were incubated with protonated EPT solution (6.3 μM), C8-EPT-pH8 or C8-EPT-pH4 (6.7 μM C8 and 6.3 μM EPT, which correspond to the concentration of 8X samples used in cytotoxicity study) for 4 h at 37 °C. Subsequently, the cells were washed by 4 °C PBS three times and collected. The fluorescence intensity of EPT in the cells was measured using a BD FACSCalibur flow cytometry (BD bioscience, USA). Untreated cells and cells treated with C8 solutions (nanostructured or unstructured) served as negative controls. Charged amino acids, light blue diamonds; uncharged hydrophilic residues, red circles; hydrophobic residues, green diamonds (intensity of green indicates hydrophobicity). (B) The mechanism of the intermolecular forces controlled self-assembly/disassembly of C8. The colors represent different types of forces provided by the side chains of amino acids. Depending on the protonation status of histidine residues, the overall intermolecular forces could become repulsive, leading to unstructured C8 monomers, or become attractive, leading to fibrous self-assemblies. (C) The nanofibers limit the contact between C8 peptide and cell membranes, while disassembled C8 
